Suven Life Sciences Limited
NSE: SUVEN BSE: SUVEN
NSE
266.80
-5.57 (-2.05%)
Prev Close
272.37
Open Price
275.6
Volume
73,236
Today Low / High
265 / 278
52 WK Low / High
102.5 / 299.99
Range
253 - 280
BSE
269.25
-4.05 (-1.48%)
Prev Close
273.3
Open Price
269.15
Volume
10,229
Today Low / High
265 / 279.9
52 WK Low / High
102.7 / 303
Range
256 - 283
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 266.8 (target range: 253 - 280), reflecting a change of -5.57 (-2.04501%). On the BSE, it is listed at 269.25 (target range: 256 - 283), showing a change of -4.05 (-1.48189%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
01 Aug
275.60
-3.19%
31 Jul
262.50
3.76%
30 Jul
283.00
-4.84%
29 Jul
276.90
1.18%
28 Jul
280.93
-1.75%
25 Jul
280.15
0.36%
24 Jul
289.98
-1.06%
23 Jul
289.88
-1.61%
22 Jul
286.40
1.22%
21 Jul
291.00
-1.58%
18 Jul
290.00
0.35%
17 Jul
294.00
-1.30%
16 Jul
299.75
-1.84%
15 Jul
288.00
2.99%
14 Jul
284.80
1.64%
11 Jul
266.95
3.63%
10 Jul
260.00
3.88%
09 Jul
266.93
-1.51%
08 Jul
275.90
-1.83%
07 Jul
260.00
3.02%
04 Jul
251.75
1.33%
Suven Life Sciences Limited Graph
Suven Life Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Suven Life Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 266.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 269.25 | 271.94 | 244.75 - 299.14 |
| 274.64 | 219.71 - 329.56 | ||
| 277.33 | 194.13 - 360.53 | ||
| Bearish Scenario | 269.25 | 266.56 | 239.90 - 293.21 |
| 263.87 | 211.09 - 316.64 | ||
| 261.17 | 182.82 - 339.52 |
Overview of Suven Life Sciences Limited
ISIN
INE495B01038
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
943,999
Market Cap
58,182,143,200
Last Dividend
0
Official Website
IPO Date
2003-10-24
DCF Diff
269.15
DCF
-2
Financial Ratios Every Investor Needs
Stock Dividend of SUVEN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2019-02-14 | February 14, 19 | 1.38194 | 1.5 | 2019-02-15 | 2019-02-25 | 2019-01-29 |
| 2018-02-06 | February 06, 18 | 1.38194 | 1.5 | 2018-02-07 | 2018-03-01 | 2018-01-19 |
| 2017-02-08 | February 08, 17 | 0.9213 | 1 | 2017-02-09 | 2017-03-03 | 2017-01-23 |
| 2016-03-14 | March 14, 16 | 0.9213 | 1 | 2016-03-15 | 2016-03-23 | 2016-03-05 |
| 2015-07-23 | July 23, 15 | 0.55278 | 0.6 | 2015-07-24 | 2015-09-13 | 2015-05-26 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.66 Cr | 34.29 Cr | -27.63 Cr | -4.1518 | 143.96 Cr | 0.00 Cr | -171.60 Cr | -160.75 Cr | -7.36 | -154.88 Cr | -24.1511 |
| 2024-03-31 | 11.69 Cr | 0.82 Cr | 10.87 Cr | 0.9295 | 114.43 Cr | 2.71 Cr | -122.58 Cr | -105.08 Cr | -4.82 | -99.28 Cr | -8.9863 |
| 2023-03-31 | 13.54 Cr | 0.57 Cr | 12.97 Cr | 0.9582 | 115.35 Cr | 2.53 Cr | -131.92 Cr | -118.27 Cr | -7.50 | -111.31 Cr | -8.7352 |
| 2022-03-31 | 11.84 Cr | 2.43 Cr | 9.41 Cr | 0.7946 | 106.37 Cr | 2.49 Cr | -126.22 Cr | -122.00 Cr | -7.73 | -116.93 Cr | -10.2999 |
| 2021-03-31 | 13.48 Cr | 0.10 Cr | 13.38 Cr | 0.9924 | 71.03 Cr | 2.29 Cr | -83.28 Cr | -72.15 Cr | -4.57 | -72.19 Cr | -5.3531 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.73 Cr | 135.18 Cr | 25.20 Cr | 109.9868 Cr | 0.00 Cr | -37.73 Cr | 0.24 Cr | 59.48 Cr | 0.00 Cr | 0.00 Cr | 0.05 Cr | 23.4860 Cr |
| 2024-03-31 | 14.93 Cr | 284.90 Cr | 14.86 Cr | 270.0406 Cr | 0.71 Cr | -14.22 Cr | 0.71 Cr | 28.01 Cr | 0.00 Cr | 0.00 Cr | 0.02 Cr | 13.5161 Cr |
| 2023-03-31 | 37.02 Cr | 388.91 Cr | 13.59 Cr | 375.3193 Cr | 1.61 Cr | -35.41 Cr | 0.01 Cr | 37.02 Cr | 7.89 Cr | 0.00 Cr | 100.00 Cr | 11.1296 Cr |
| 2022-03-31 | 5.27 Cr | 108.03 Cr | 11.89 Cr | 96.1454 Cr | 3.21 Cr | -2.07 Cr | 0.02 Cr | 40.89 Cr | 4.09 Cr | 0.00 Cr | 0.00 Cr | 8.3147 Cr |
| 2021-03-31 | 9.35 Cr | 128.42 Cr | 20.41 Cr | 108.0057 Cr | 4.76 Cr | -4.58 Cr | 0.14 Cr | 25.60 Cr | 10.16 Cr | 0.00 Cr | -0.09 Cr | 15.9095 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -148.4687 Cr | 149.2715 Cr | -0.7097 Cr | -185.7445 Cr | 0.0000 Cr | 37.7263 Cr | -37.2758 Cr | -160.7450 Cr | 0.0000 Cr | 0.0000 Cr | 0.4710 Cr |
| 2024-03-31 | -115.4690 Cr | 94.4363 Cr | -1.0540 Cr | -115.4690 Cr | -22.0867 Cr | 14.9324 Cr | 0.0000 Cr | -105.0763 Cr | 0.0000 Cr | 0.0000 Cr | -0.7084 Cr |
| 2023-03-31 | -103.1482 Cr | -260.6454 Cr | 395.5391 Cr | -106.0430 Cr | 31.7455 Cr | 37.0191 Cr | -2.8948 Cr | -118.2678 Cr | -0.4843 Cr | 0.0000 Cr | 0.0224 Cr |
| 2022-03-31 | -127.5370 Cr | -22.2292 Cr | 145.6916 Cr | -147.3086 Cr | -4.0746 Cr | 5.2736 Cr | -19.7716 Cr | -121.9951 Cr | -0.8523 Cr | 0.0000 Cr | 0.1191 Cr |
| 2021-03-31 | -96.0236 Cr | 55.8404 Cr | 34.8556 Cr | -102.3283 Cr | -5.3275 Cr | 9.3482 Cr | -6.3047 Cr | -77.4741 Cr | -0.6924 Cr | 0.0000 Cr | -0.1415 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 9.31 Cr | -7.84 Cr | -5.3459 | -45.17 Cr | -43.94 Cr | -2.01 | -42.60 Cr | -29.9556 |
| 2024-12-31 | 1.61 Cr | 0.00 Cr | 1.61 Cr | 1.0000 | -40.74 Cr | -39.12 Cr | -1.79 | -37.58 Cr | -24.2975 |
| 2024-09-30 | 2.57 Cr | 8.65 Cr | -6.08 Cr | -2.3627 | -53.66 Cr | -49.64 Cr | -2.27 | -48.17 Cr | -19.2949 |
| 2024-06-30 | 1.01 Cr | 8.11 Cr | -7.11 Cr | -7.0638 | -32.02 Cr | -28.04 Cr | -1.29 | -26.53 Cr | -27.8725 |
| 2024-03-31 | 2.39 Cr | 6.66 Cr | -4.27 Cr | -1.7921 | -31.80 Cr | -26.54 Cr | -1.68 | -26.00 Cr | -11.1272 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 37.73 Cr | 22.28 Cr | 60.00 Cr | 1.34 Cr | 0.24 Cr | 75.47 Cr | 59.48 Cr | 135.18 Cr | 25.20 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 166.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -192.68 Cr |
| 2024-09-30 | 7.44 Cr | 161.46 Cr | 166.48 Cr | 1.48 Cr | 0.70 Cr | 186.56 Cr | 25.16 Cr | 211.96 Cr | 19.28 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 239.87 Cr | 0.00 Cr | 0.00 Cr | 239.87 Cr | 0.00 Cr | 0.00 Cr | -270.04 Cr |
| 2024-03-31 | 163.98 Cr | 75.94 Cr | 239.91 Cr | 1.29 Cr | 0.71 Cr | 256.67 Cr | 28.01 Cr | 284.90 Cr | 14.86 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -39.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -49.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -28.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -26.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -41.76 Cr | 3.21 Cr | 0.00 Cr | 0.00 Cr | 3.21 Cr | 127.17 Cr | 123.97 Cr | 0.00 Cr | 3.21 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-10-17 | October 17, 22 | 217:200 |
| 2007-03-23 | March 23, 07 | 2:1 |
| 2004-01-15 | January 15, 04 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,629.70 | ₹3,910,106,616,000.00 | ₹8,774,003.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,361.50 | ₹1,688,781,043,500.00 | ₹467,198.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,678.20 | ₹1,244,868,399,000.00 | ₹605,655.00 |
| Mankind Pharma Limited | MANKIND | ₹2,566.30 | ₹1,059,185,816,788.00 | ₹537,190.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,220.60 | ₹1,015,944,530,745.00 | ₹2,525,040.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹949.05 | ₹954,962,581,500.00 | ₹1,284,643.00 |
| Lupin Limited | LUPIN | ₹1,867.30 | ₹852,883,673,100.00 | ₹1,243,056.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,079.80 | ₹627,149,999,600.00 | ₹2,025,363.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,899.00 | ₹585,748,935,000.00 | ₹220,552.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,067.80 | ₹583,535,227,800.00 | ₹1,484,673.00 |
| Laurus Labs Limited | LAURUSLABS | ₹849.35 | ₹458,282,930,150.00 | ₹2,232,947.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹979.35 | ₹374,666,999,285.00 | ₹293,950.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,450.20 | ₹367,921,540,800.00 | ₹151,738.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,695.20 | ₹336,662,822,400.00 | ₹87,351.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,738.00 | ₹271,680,684,000.00 | ₹376,454.00 |
| Piramal Enterprises Limited | PEL | ₹1,197.10 | ₹271,356,233,800.00 | ₹785,375.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,612.40 | ₹261,981,139,600.00 | ₹397,252.00 |
| Eris Lifesciences Limited | ERIS | ₹1,808.40 | ₹246,316,738,800.00 | ₹96,925.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,893.50 | ₹222,337,500,000.00 | ₹16,505.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹959.05 | ₹188,513,745,150.00 | ₹79,521.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,158.40 | ₹184,511,110,400.00 | ₹305,979.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,017.00 | ₹167,006,808,300.00 | ₹308,850.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹931.05 | ₹166,760,365,500.00 | ₹527,101.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,988.10 | ₹151,118,860,770.00 | ₹83,585.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹451.75 | ₹109,614,427,000.00 | ₹1,307,239.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,217.00 | ₹103,198,469,800.00 | ₹240,924.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹857.25 | ₹83,831,249,025.00 | ₹56,291.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹864.00 | ₹78,308,311,680.00 | ₹305,019.00 |
| FDC Limited | FDC | ₹475.40 | ₹77,399,874,000.00 | ₹81,191.00 |
| Strides Pharma Science Limited | STAR | ₹836.55 | ₹77,098,706,685.00 | ₹1,056,174.00 |
| Suven Life Sciences Limited | SUVEN | ₹266.80 | ₹58,182,143,200.00 | ₹73,236.00 |
| Innova Captab Limited | INNOVACAP | ₹887.70 | ₹50,798,570,361.00 | ₹60,391.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹149.84 | ₹48,626,376,480.00 | ₹306,698.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹489.45 | ₹44,672,101,500.00 | ₹382,816.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹607.40 | ₹42,764,482,920.00 | ₹22,251.00 |
| Sequent Scientific Limited | SEQUENT | ₹168.61 | ₹42,208,984,350.00 | ₹208,300.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹777.40 | ₹39,429,028,340.00 | ₹70,572.00 |
| Hikal Limited | HIKAL | ₹317.25 | ₹39,117,242,250.00 | ₹349,343.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,350.70 | ₹38,878,227,300.00 | ₹12,442.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹384.65 | ₹38,571,932,700.00 | ₹59,308.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹57.78 | ₹31,660,782,120.00 | ₹1,546,957.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹604.40 | ₹30,249,837,415.00 | ₹211,239.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹100.17 | ₹29,402,599,590.00 | ₹3,041,393.00 |
| Alembic Limited | ALEMBICLTD | ₹111.21 | ₹28,556,726,109.00 | ₹250,016.00 |
| Indoco Remedies Limited | INDOCO | ₹309.35 | ₹28,536,887,865.00 | ₹36,824.00 |
Key Executives
President of US Operations
Ms. Kalyani Jasti
Gender: female
Year Born: 1979
Chief Executive Officer, MD & Executive Chairman
Mr. Venkateswarlu Jasti M.Pharm. M.S.
Gender: male
Year Born: 1949
Chief Financial Officer
Mr. M. Mohan Kumar C.M.A.
Gender: male
Year Born:
Whole-Time Director
Ms. Sudharani Jasti B.Sc.
Gender: female
Year Born: 1954
Company Secretary & Compliance Officer
Mr. Kundan Kumar Jha
Gender: male
Year Born:
FAQs about Suven Life Sciences Limited
Who is the CEO of the company?
The CEO is Venkateswarlu Jasti M.Pharm..
What is the current market price of the stock?
The current price is ₹266.80.
What is the 52-week price range?
The range is ₹102.5-299.99.
What is the market capitalization of the company?
The market capitalization is ₹5,818.21 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -36.25.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Suven Life Sciences Limited (ISIN: INE495B01038) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹5,818.21 crores and an average daily volume of 943,999 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.